Fresenius Medical Care AG & Co. KGaA (FMS) Competitors $25.11 -0.23 (-0.91%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$25.12 +0.01 (+0.04%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FMS vs. ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, and HIMSShould you be buying Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? The main competitors of Fresenius Medical Care AG & Co. KGaA include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Fresenius Medical Care AG & Co. KGaA vs. Its Competitors Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Hims & Hers Health Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability. Do insiders and institutionals hold more shares of FMS or ACONW? 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts rate FMS or ACONW? Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $27.80, indicating a potential upside of 10.71%. Given Fresenius Medical Care AG & Co. KGaA's stronger consensus rating and higher probable upside, equities research analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Aclarion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fresenius Medical Care AG & Co. KGaA 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Aclarion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is FMS or ACONW more profitable? Fresenius Medical Care AG & Co. KGaA has a net margin of 3.18% compared to Aclarion's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 6.25% beat Aclarion's return on equity.Company Net Margins Return on Equity Return on Assets Fresenius Medical Care AG & Co. KGaA3.18% 6.25% 2.88% Aclarion N/A N/A N/A Which has higher valuation and earnings, FMS or ACONW? Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Aclarion. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFresenius Medical Care AG & Co. KGaA$20.63BN/A$582.08M$1.1222.42Aclarion$54.60KN/AN/AN/AN/A Does the media prefer FMS or ACONW? In the previous week, Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.33 beat Aclarion's score of 0.00 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Overall Sentiment Fresenius Medical Care AG & Co. KGaA Neutral Aclarion Neutral SummaryFresenius Medical Care AG & Co. KGaA beats Aclarion on 9 of the 9 factors compared between the two stocks. Get Fresenius Medical Care AG & Co. KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FMS vs. The Competition Export to ExcelMetricFresenius Medical Care AG & Co. KGaAMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket CapN/A$6.80B$5.52B$20.47BDividend Yield2.27%1.31%4.74%3.71%P/E Ratio22.4220.9028.8829.04Price / SalesN/A59.12440.8757.15Price / Cash5.1620.4535.0722.46Price / Book0.864.468.254.43Net Income$582.08M$176.39M$3.25B$993.74M7 Day Performance-4.90%-5.27%-3.75%-3.40%1 Month Performance-10.70%-4.11%2.99%-2.70%1 Year Performance31.81%9.37%25.35%10.16% Fresenius Medical Care AG & Co. KGaA Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FMSFresenius Medical Care AG & Co. KGaA3.5142 of 5 stars$25.11-0.9%$27.80+10.7%+31.8%$0.00$20.63B22.421,384Positive NewsACONWAclarionN/A$0.03-1.5%N/AN/A$0.00$54.60K0.007Gap DownAONCAmerican Oncology NetworkN/A$11.00+10.0%N/A+273.8%$0.00$1.34B0.001,520Gap UpHigh Trading VolumeDHACWDigital Health AcquisitionN/A$0.05-8.9%N/A-58.0%$0.00N/A0.00N/AGap DownLFMDPLifeMDN/A$23.85+1.9%N/A+9.5%$0.00$234.01M0.00230Upcoming EarningsOTRKPOntrakN/A$0.24+4.1%N/A-87.4%$0.00$10.84M0.00250Upcoming EarningsPIIIWP3 Health PartnersN/A$0.01-5.0%N/A-73.7%$0.00$1.49B0.00500Gap DownTALKWTalkspaceN/A$0.07+10.5%N/A-15.7%$0.00$194.36M0.00500Gap UpTOIIWOncology InstituteN/A$0.10+0.5%N/A+416.0%$0.00$403.15M0.00660NTRANatera3.6676 of 5 stars$140.63+1.2%$184.63+31.3%+35.1%$19.20B$1.83B-95.674,434Trending NewsInsider TradeHIMSHims & Hers Health2.5516 of 5 stars$47.66-5.4%$39.83-16.4%+256.3%$10.67B$1.48B69.071,637Trending NewsUpcoming EarningsInsider TradeGap Down Related Companies and Tools Related Companies ACONW Competitors AONC Competitors DHACW Competitors LFMDP Competitors OTRKP Competitors PIIIW Competitors TALKW Competitors TOIIW Competitors NTRA Competitors HIMS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:FMS) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius Medical Care AG & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius Medical Care AG & Co. KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
